Biomedica is a research and development company that fosters the development of critical technologies. Its research program began in 1999 with a partnership set up to bridge the funding gap that exists between science and business. The partnership included leading scientists in the field of fibrinogen biochemistry, immunology, polymer chemistry, and trauma surgery. Biomedica Management Corporation is a clinical-stage federally funded research and development company. The company operates under an innovative business model that fosters the development of critical technologies with the vision of academic scientists. Biomedica brings to the market affordable and effective technologies targeting unmet needs in coagulopathic-related conditions, inflammation, and wound healing.
Biomedica is headquartered at the UMBC TechCenter in Baltimore, Maryland.,